Keyphrases
Intranasal
100%
Orexin
100%
Coma
100%
Neuroinflammation
100%
Arousal
100%
In-hospital Cardiac Arrest
100%
Orexin Receptors
62%
Cardiac Arrest
50%
Hypothalamus
37%
Brain Regions
25%
Inflammatory Markers
25%
Resuscitation
25%
Neurological Outcome
12%
Prefrontal Cortex
12%
Poor Outcome
12%
Inducible Nitric Oxide Synthase
12%
Ischemia
12%
Inflammatory Cytokines
12%
MRNA Level
12%
Rat Model
12%
Inflammatory Response
12%
Neurologic Deficit
12%
Hippocampus
12%
Significant Risk Factors
12%
CD11b
12%
Functional Outcome
12%
Whole-body
12%
Anti-inflammatory Effect
12%
Electroencephalogram
12%
Cardiac Dysfunction
12%
Trauma Resuscitation
12%
Therapeutic Hypothermia
12%
Neuroprotective Therapy
12%
Intranasal Delivery
12%
Behavioral Outcomes
12%
Clinical Approach
12%
Quantitative Electroencephalography (qEEG)
12%
Cardiac Arrest Outcomes
12%
Beneficial Outcomes
12%
Return of Spontaneous Circulation
12%
Cerebral Dysfunction
12%
Cardiac Arrest Survivor
12%
Behavioral Recovery
12%
Post-cardiac Arrest Syndrome
12%
Cortical Arousal
12%
Cognitive Arousal
12%
Subsequent Morbidity
12%
Neuroinflammatory Markers
12%
Pharmacology, Toxicology and Pharmaceutical Science
Coma
100%
Nervous System Inflammation
100%
Heart Arrest
100%
Orexin A
100%
Syndrome
16%
Orexin Receptor
16%
Inflammation
8%
Ischemia
8%
Neuroprotective Agent
8%
Cytokine
8%
Tumor Necrosis Factor
8%
Rat Model
8%
Antiinflammatory Activity
8%
Hypothermia
8%
Biochemistry, Genetics and Molecular Biology
Coma
100%
K-Complex
100%
Cardiac Arrest
100%
Orexin-A
100%
Electroencephalogram
16%
Orexin Receptor
16%
Messenger RNA
8%
Rat Model
8%
Tumor Necrosis Factor
8%
Proinflammatory Cytokine
8%
Hypothermia
8%
Antiinflammatory Activity
8%
Medical Decision Making
8%
Return of Spontaneous Circulation
8%
Neuroscience
Coma
100%
Orexin-A
100%
Hypothalamus
37%
Orexin Receptor
25%
Electroencephalogram
25%
Prefrontal Cortex
12%
Hippocampus
12%
Hypothermia
12%
Ischemia
12%
Proinflammatory Cytokine
12%
Anti-Inflammatory
12%
Neuroprotective Agent
12%